Evotec SE is a life science company focused on drug discovery and development. It offers a range of services including small molecules, biologics, and cell therapies, utilizing advanced technologies and AI-driven innovation. The company partners with pharmaceutical companies, biotech firms, and academic institutions, providing both standalone services and fully integrated R&D programs. Evotec operates globally, concentrating on therapeutic areas such as oncology, cardiovascular and metabolic diseases, neurology, and immunology.
- Website
- www.evotec.com
- Issuer profile
- All listings